Pleomorphic adenoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for the [[secondary prevention]] of pleomorphic adenoma include timely [[Radiological|radiologic]] [[imaging]], [[blood tests]] | Effective measures for the [[secondary prevention]] of pleomorphic adenoma include timely [[physical examination]], [[Radiological|radiologic]] [[imaging]], [[blood tests]]. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Secondary preventive measures include timely [[screening]] at regular intervals with routine [[physical examination]], [[radiological]] [[imaging]], and [[blood tests]]. | *Secondary preventive measures include timely [[screening]] at regular intervals with routine [[physical examination]], [[radiological]] [[imaging]], and [[blood tests]]. | ||
*Once diagnosed and successfully treated, [[patients]] with pleomorphic adenoma are followed-up every 6 or 12 months. | *Once diagnosed and successfully treated, [[patients]] with pleomorphic adenoma are followed-up every 6 or 12 months. | ||
Latest revision as of 20:30, 28 January 2019
|
Pleomorphic adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleomorphic adenoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pleomorphic adenoma secondary prevention |
|
Risk calculators and risk factors for Pleomorphic adenoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
Effective measures for the secondary prevention of pleomorphic adenoma include timely physical examination, radiologic imaging, blood tests.
Secondary Prevention
- Secondary preventive measures include timely screening at regular intervals with routine physical examination, radiological imaging, and blood tests.
- Once diagnosed and successfully treated, patients with pleomorphic adenoma are followed-up every 6 or 12 months.